Literature DB >> 19337313

Hereditary haemorrhagic telangiectasia: a clinical and scientific review.

Fatima S Govani1, Claire L Shovlin.   

Abstract

The autosomal-dominant trait hereditary haemorrhagic telangiectasia (HHT) affects 1 in 5-8000 people. Genes mutated in HHT (most commonly for endoglin or activin receptor-like kinase (ALK1)) encode proteins that modulate transforming growth factor (TGF)-beta superfamily signalling in vascular endothelial cells; mutations lead to the development of fragile telangiectatic vessels and arteriovenous malformations. In this article, we review the underlying molecular, cellular and circulatory pathobiology; explore HHT clinical and genetic diagnostic strategies; present detailed considerations regarding screening for asymptomatic visceral involvement; and provide overviews of management strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19337313      PMCID: PMC2986493          DOI: 10.1038/ejhg.2009.35

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  57 in total

1.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism.

Authors: 
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

2.  No live individual homozygous for a novel endoglin mutation was found in a consanguineous Arab family with hereditary haemorrhagic telangiectasia.

Authors:  A Karabegovic; M Shinawi; U Cymerman; M Letarte
Journal:  J Med Genet       Date:  2004-11       Impact factor: 6.318

3.  Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.

Authors:  R C Trembath; J R Thomson; R D Machado; N V Morgan; C Atkinson; I Winship; G Simonneau; N Galie; J E Loyd; M Humbert; W C Nichols; N W Morrell; J Berg; A Manes; J McGaughran; M Pauciulo; L Wheeler
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

4.  Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).

Authors:  C L Shovlin; A E Guttmacher; E Buscarini; M E Faughnan; R H Hyland; C J Westermann; A D Kjeldsen; H Plauchu
Journal:  Am J Med Genet       Date:  2000-03-06

5.  Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.

Authors:  J Berg; M Porteous; D Reinhardt; C Gallione; S Holloway; T Umasunthar; A Lux; W McKinnon; D Marchuk; A Guttmacher
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

Review 6.  Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century.

Authors:  M E Begbie; G M F Wallace; C L Shovlin
Journal:  Postgrad Med J       Date:  2003-01       Impact factor: 2.401

Review 7.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

Authors:  Rik Derynck; Ying E Zhang
Journal:  Nature       Date:  2003-10-09       Impact factor: 49.962

8.  Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.

Authors:  Marie José Goumans; Gudrun Valdimarsdottir; Susumu Itoh; Franck Lebrin; Jonas Larsson; Christine Mummery; Stefan Karlsson; Peter ten Dijke
Journal:  Mol Cell       Date:  2003-10       Impact factor: 17.970

9.  A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4).

Authors:  Carol J Gallione; Gabriela M Repetto; Eric Legius; Anil K Rustgi; Susan L Schelley; Sabine Tejpar; Grant Mitchell; Eric Drouin; Cornelius J J Westermann; Douglas A Marchuk
Journal:  Lancet       Date:  2004-03-13       Impact factor: 79.321

10.  Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome.

Authors:  M G Dunlop
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

View more
  139 in total

Review 1.  Pathogenesis of vascular anomalies.

Authors:  Laurence M Boon; Fanny Ballieux; Miikka Vikkula
Journal:  Clin Plast Surg       Date:  2011-01       Impact factor: 2.017

Review 2.  Bleeding and clotting in hereditary hemorrhagic telangiectasia.

Authors:  Christopher Dittus; Michael Streiff; Jack Ansell
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

Review 3.  Veins and Arteries Build Hierarchical Branching Patterns Differently: Bottom-Up versus Top-Down.

Authors:  Kristy Red-Horse; Arndt F Siekmann
Journal:  Bioessays       Date:  2019-03       Impact factor: 4.345

4.  Hereditary haemorrhagic telangiectasia and genetic thrombophilia.

Authors:  S Bianca; N Cutuli; M Bianca; B Barrano; A Cataliotti; C Barone; L Indaco; G Milana
Journal:  Eur J Hum Genet       Date:  2009-11-11       Impact factor: 4.246

5.  Hereditary haemorrhagic telangiectasia: From symptomatic management to pathogenesis based treatment.

Authors:  Francisco José Fernández-Fernández
Journal:  Eur J Hum Genet       Date:  2009-11-04       Impact factor: 4.246

6.  Hereditary Hemorrhagic Telangiectasia: Breakpoint Characterization of a Novel Large Deletion in ACVRL1 Suggests the Causing Mechanism.

Authors:  Laura Boeri; Orietta Radi; Cecilia Canzonieri; Elisabetta Buscarini; Agnese Scatigno; Antonella Minelli; Federica Ornati; Fabio Pagella; Cesare Danesino; Carla Olivieri
Journal:  Mol Syndromol       Date:  2013-02-28

Review 7.  Diversity is in my veins: role of bone morphogenetic protein signaling during venous morphogenesis in zebrafish illustrates the heterogeneity within endothelial cells.

Authors:  Jun-Dae Kim; Heon-Woo Lee; Suk-Won Jin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07-24       Impact factor: 8.311

8.  Rare manifestations in a case of Osler-Weber-Rendu disease.

Authors:  Abhijai Singh; Vikas Suri; Sanjay Jain; Subhash Varma
Journal:  BMJ Case Rep       Date:  2015-01-05

Review 9.  Vascular anomalies: from genetics toward models for therapeutic trials.

Authors:  Melanie Uebelhoer; Laurence M Boon; Miikka Vikkula
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

10.  Characterization of the human Activin-A receptor type II-like kinase 1 (ACVRL1) promoter and its regulation by Sp1.

Authors:  Eva M Garrido-Martin; Francisco J Blanco; Africa Fernandez-L; Carmen Langa; Calvin P Vary; Ursula E Lee; Scott L Friedman; Luisa M Botella; Carmelo Bernabeu
Journal:  BMC Mol Biol       Date:  2010-06-29       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.